- 米国企業
- Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc.MD
| 2010年
12月31日 | 2011年
12月31日 | 2012年
12月31日 | 2013年
12月31日 | 2014年
12月31日 | 2015年
12月31日 | 2016年
12月31日 | 2017年
12月31日 | 2018年
12月31日 | 2019年
12月31日 | 2020年
12月31日 | 2021年
12月31日 | 2022年
12月31日 |
|---|
| Net Income (loss) | 203 | 218 | 241 | 281 | 317 | 336 | 325 | 320 | 269 | -1,498 | -796 | 131 | 66 |
|---|
| (Income) loss from discontinued operations | - | - | - | - | - | - | - | - | - | -348 | -787 | 23 | 4 |
|---|
| Depreciation and amortization | 22 | 25 | 31 | 40 | 46 | 64 | 89 | 103 | 111 | 79 | 28 | 32 | 36 |
|---|
| Amortization of Debt Issuance Costs and Discounts | - | - | - | - | - | - | 5 | 6 | 5 | 6 | 7 | 4 | 2 |
|---|
| Loss on early extinguishment of debt | - | - | - | - | - | - | - | - | - | - | - | -15 | -57 |
|---|
| Stock-based compensation expense | 26 | 27 | 28 | 31 | 32 | 32 | 34 | 30 | 39 | 35 | 39 | 19 | 16 |
|---|
| Deferred income taxes | 24 | 8 | 21 | 16 | 3 | 14 | 18 | -60 | -24 | -177 | 36 | -31 | -23 |
|---|
| Gain on sale of building | - | - | - | - | - | - | - | - | - | - | - | -7 | - |
|---|
| Other | - | - | - | - | - | - | - | 4 | 11 | -0 | 0 | 2 | -0 |
|---|
| Accounts receivable | 17 | 49 | 18 | 37 | 57 | 55 | 34 | -8 | 37 | -8 | -38 | 73 | 6 |
|---|
| Prepaid expenses and other current assets | -4 | 3 | 0 | -0 | -2 | 5 | 1 | 3 | 5 | 10 | 48 | -42 | -16 |
|---|
| Other long-term assets | - | - | - | - | - | - | -10 | 3 | 0 | -38 | -14 | -10 | -17 |
|---|
| Accounts payable and accrued expenses | -37 | 21 | 17 | 49 | 66 | -8 | 12 | 25 | 15 | 104 | 48 | 21 | 0 |
|---|
| Income taxes receivable (payable) | 19 | 7 | -7 | 6 | 7 | -4 | -2 | 73 | -61 | -24 | -7 | -2 | 18 |
|---|
| Payment of contingent consideration liabilities | - | - | - | - | - | - | - | 1 | 1 | 1 | - | 0 | - |
|---|
| Long-term professional liabilities | - | - | - | - | - | - | - | - | -4 | 10 | 4 | 2 | 6 |
|---|
| Other liabilities | -0 | 2 | 0 | 1 | 2 | -3 | -7 | -1 | -4 | -28 | 4 | -23 | -20 |
|---|
| Net cash provided by operating activities – continuing operations | - | - | - | - | 423 | 369 | 444 | 511 | - | 338 | 154 | 114 | 182 |
|---|
| Cash Provided by (Used in) Operating Activities, Discontinued Operations | - | - | - | - | - | - | - | - | - | 8 | 51 | -37 | -15 |
|---|
| Net cash provided by operating activities | 241 | 271 | 326 | 405 | - | - | - | - | 290 | 347 | 205 | 77 | 167 |
|---|
| Acquisition payments, net of cash acquired | 339 | 155 | 441 | 238 | 479 | 819 | 762 | 532 | 114 | 112 | 2 | -30 | 28 |
|---|
| Purchases of investments | 26 | 43 | 33 | 21 | 27 | 34 | 61 | 28 | 16 | 35 | 62 | 15 | 17 |
|---|
| Proceeds from maturities or sales of investments | 16 | 38 | 28 | 11 | 21 | 32 | 41 | 25 | 14 | 51 | 33 | 16 | 17 |
|---|
| Purchases of property and equipment | 12 | 31 | 14 | 16 | 18 | 27 | 39 | 49 | 49 | 32 | 29 | 32 | 30 |
|---|
| Proceeds from sale of buildings | - | - | - | - | - | - | - | - | - | - | - | 25 | - |
|---|
| Strategic investments | - | - | - | - | - | - | - | - | - | - | - | -20 | - |
|---|
| Other | - | - | - | - | - | - | - | - | - | - | - | 1 | 1 |
|---|
| Net cash (used in) provided by investing activities – continuing operations | - | - | - | - | -504 | -848 | -821 | -577 | - | 122 | -58 | -55 | -57 |
|---|
| Net cash provided by investing activities - discontinued operations | - | - | - | - | - | - | - | - | - | -19 | 874 | 2 | - |
|---|
| Net cash (used in) provided by investing activities | -362 | -191 | -461 | -263 | - | - | - | - | -143 | 102 | 816 | -53 | -57 |
|---|
| Proceeds from Lines of Credit | 684 | 513 | 518 | 912 | 1,755 | 2,122 | 1,940 | 2,846 | 1,724 | 1,247 | 528 | - | 830 |
|---|
| Payments on credit agreement | 588 | 630 | 403 | 1,029 | 1,214 | 2,156 | 1,510 | 2,699 | 2,095 | 1,987 | 528 | - | 826 |
|---|
| Redemption of senior notes, including call premium | - | - | - | - | - | - | - | - | - | - | - | 760 | 1,047 |
|---|
| Proceeds from issuance of senior notes | - | - | - | - | - | 750 | - | - | 500 | 500 | - | - | 650 |
|---|
| Payments on term loan | - | - | - | - | - | - | - | - | - | - | - | - | 9 |
|---|
| Payments for credit facility amendment and financing costs | - | - | - | - | 4 | 14 | - | 4 | 7 | 9 | 1 | - | 9 |
|---|
| Payments of contingent consideration liabilities | - | - | - | - | - | - | - | 5 | 5 | 10 | - | 0 | - |
|---|
| Payments on finance lease obligations | - | - | - | - | - | - | - | - | - | - | - | 3 | 3 |
|---|
| Proceeds from issuance of common stock | 23 | 31 | 29 | 29 | 43 | 20 | 22 | 23 | 16 | 11 | 7 | 7 | 5 |
|---|
| Repurchases of common stock | - | - | - | 52 | 488 | 235 | 62 | 70 | 302 | 145 | 8 | 5 | 89 |
|---|
| Proceeds from Noncontrolling Interests | - | - | - | - | 1 | - | - | 1 | - | - | 0 | - | - |
|---|
| Other | - | - | - | - | - | - | - | - | - | - | - | 1 | 9 |
|---|
| Net cash used in financing activities – continuing operations | - | - | - | - | 98 | 483 | 382 | 90 | - | -393 | -3 | -760 | -488 |
|---|
| Net cash used in financing activities – discontinued operations | - | - | - | - | - | - | - | - | - | - | -1 | - | - |
|---|
| Net cash used in financing activities | 121 | -88 | 138 | -132 | - | - | - | - | -171 | -393 | -4 | -760 | -488 |
|---|
| Net (decrease) increase in cash and cash equivalents | - | - | - | - | - | - | - | - | -23 | 56 | 1,016 | -736 | -378 |
|---|
| Interest | - | 3 | 2 | 3 | 7 | 20 | 60 | 74 | 83 | 95 | 110 | 87 | 116 |
|---|
| Income taxes | 89 | 119 | 130 | 126 | 162 | 181 | 176 | 75 | 185 | 86 | -28 | 55 | 27 |
|---|
| Lease Obligation Incurred | - | 1 | - | - | 1 | 3 | 2 | 1 | - | - | 13 | 7 | 0 |
|---|
| Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 3 |
|---|